Â鶹ԼÅÄ

PHONE-IN
The first drug to slow the destruction of the brain in Alzheimer's has been heralded as momentous.
The research breakthrough ends decades of failure and shows a new era of drugs to treat Alzheimer's - the most common form of dementia - is possible. Yet the medicine, lecanemab, has only a small effect and its impact on people's daily lives is debated. And the drug works in the early stages of the disease, so most would miss out without a revolution in spotting it. Lecanemab attacks the sticky gunge - called beta amyloid - that builds up in the brains of people with Alzheimer's.
For a medical field littered with duds, despair and disappointment, some see these trial results as a triumphant turning point. Alzheimer's Research UK said the findings were "momentous".

Stephen asks - How has Alzheimer’s affected your family?

Also on the show…

STRICTLY LIVE - ELLIE SIMMONDS
We catch up with Strictly Star & Paralympian Ellie Simmonds

SANTA DEMAND
We hear from Father Christmas about how busy he is after two difficult years

FESTIVE ANXIETY
How to manage if you are feeling anxious about the festive period

ASK THE DOC
On our weekly health surgery GP Dr Punam Krishan is on hand to answer listener questions

ADVENT CALENDARS
When did advent calendars go OTT?

GO GALA
As Galashiels is named the second happiest place to live in the UK, we’ll find out what’s so great about the town